Cancer of the Endocrine System

Ammar Asban, Anish J. Patel, Sushanth Reddy, Thomas Wang, Courtney J. Balentine, Herbert Chen

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Unlike tumors found elsewhere in the body, cancers of the endocrine organs can cause symptoms of hormonal excess in addition to mass effect, obstruction, or pain from the mass itself. Therefore physicians who care for patients with endocrine cancers must combat both the physiologic manifestations and the neoplasia. Any of the endocrine tumors can be part of a multitude of familial syndromes, so the clinician caring for these patients must always keep this possibility in mind. This chapter covers selected endocrine cancers and highlights some of the unique challenges in treating such tumors. Many common themes emerge. Diagnosis typically involves biochemical confirmation of the endocrinopathy followed by imaging to locate the tumor(s). Surgery plays a role in the initial treatment and often for recurrence and palliation. Traditional chemotherapy is of limited use for endocrine cancers, but newer, targeted therapies show more promise. This chapter covers thyroid cancer, including medullary thyroid cancer (MTC), adrenocortical carcinoma, malignant pheochromocytom (PCC), multiple endocrine neoplasia (MEN) syndromes, carcinoid tumors, pancreatic neuroendocrine tumors (pNETs), and parathyroid carcinoma.

Original languageEnglish (US)
Title of host publicationAbeloff’s Clinical Oncology
PublisherElsevier
Pages1074-1107.e11
ISBN (Electronic)9780323476744
DOIs
StatePublished - Jan 1 2019

Keywords

  • Adrenal
  • Pancreas
  • Parathyroid
  • Thyroid

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Cancer of the Endocrine System'. Together they form a unique fingerprint.

Cite this